Protalix Biotherapeutics, Inc. (PLX)
2.475
+0.08
(+3.12%)
USD |
NYAM |
Aug 26, 16:00
2.475
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics Price : 2.475 for Aug. 26, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 2.43 | 2.43 | 2.38 | 2.40 | 497742.0 |
| Aug 24, 2026 | 2.36 | 2.43 | 2.34 | 2.41 | 409933.0 |
| Aug 21, 2026 | 2.39 | 2.435 | 2.35 | 2.38 | 648550.0 |
| Aug 20, 2026 | 2.32 | 2.39 | 2.310 | 2.38 | 384984.0 |
| Aug 19, 2026 | 2.37 | 2.38 | 2.31 | 2.35 | 477242.0 |
| Aug 18, 2026 | 2.30 | 2.345 | 2.28 | 2.34 | 280506.0 |
| Aug 17, 2026 | 2.24 | 2.365 | 2.22 | 2.29 | 1.076M |
| Aug 14, 2026 | 2.36 | 2.36 | 2.17 | 2.22 | 995919.0 |
| Aug 13, 2026 | 2.64 | 2.64 | 2.32 | 2.36 | 2.002M |
| Aug 12, 2026 | 2.49 | 2.705 | 2.40 | 2.62 | 2.012M |
| Aug 11, 2026 | 2.47 | 2.48 | 2.410 | 2.43 | 373853.0 |
| Aug 10, 2026 | 2.48 | 2.50 | 2.41 | 2.48 | 773425.0 |
| Aug 07, 2026 | 2.43 | 2.47 | 2.425 | 2.46 | 670214.0 |
| Aug 06, 2026 | 2.44 | 2.48 | 2.42 | 2.44 | 530892.0 |
| Aug 05, 2026 | 2.39 | 2.47 | 2.36 | 2.44 | 538936.0 |
| Aug 04, 2026 | 2.33 | 2.39 | 2.32 | 2.37 | 716164.0 |
| Aug 03, 2026 | 2.36 | 2.480 | 2.30 | 2.32 | 1.027M |
| Jul 31, 2026 | 2.29 | 2.385 | 2.20 | 2.37 | 1.233M |
| Jul 30, 2026 | 2.29 | 2.30 | 2.23 | 2.27 | 267199.0 |
| Jul 29, 2026 | 2.31 | 2.36 | 2.25 | 2.27 | 578220.0 |
| Jul 28, 2026 | 2.42 | 2.42 | 2.31 | 2.33 | 382577.0 |
| Jul 27, 2026 | 2.39 | 2.46 | 2.36 | 2.40 | 567011.0 |
| Jul 24, 2026 | 2.35 | 2.39 | 2.33 | 2.37 | 212184.0 |
| Jul 23, 2026 | 2.34 | 2.385 | 2.315 | 2.37 | 449023.0 |
| Jul 22, 2026 | 2.34 | 2.39 | 2.31 | 2.37 | 276755.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Altimmune, Inc. | 3.155 |
| Taysha Gene Therapies, Inc. | 6.015 |
| Humacyte, Inc. | 0.6852 |
| Agenus, Inc. | 8.245 |
| Amgen, Inc. | 440.30 |
Price Related Metrics
| PE Ratio | 10.90 |
| PS Ratio | 2.509 |
| PEG Ratio | 0.0527 |
| Price to Book Value | 2.793 |
| Price to Free Cash Flow | 26.37 |
| Earnings Yield | 9.18% |
| Market Cap | 199.41M |
| PEGY Ratio | 0.0527 |
| Operating PE Ratio | 8.683 |
| Normalized PE Ratio | 10.90 |